American Renal Associates Holdings Inc. (NYSE:ARA) reached a new 52-week low on Tuesday . The company traded as low as $22.20 and last traded at $22.33, with a volume of 62,472 shares changing hands. The stock had previously closed at $22.70.

ARA has been the subject of a number of recent research reports. Barclays PLC initiated coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “overweight” rating and a $33.00 target price for the company. SunTrust Banks Inc. initiated coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “buy” rating and a $34.00 target price for the company. Wells Fargo & Co. initiated coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “outperform” rating for the company. Goldman Sachs Group Inc. initiated coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “neutral” rating and a $30.00 target price for the company. Finally, Leerink Swann initiated coverage on American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “outperform” rating and a $33.00 target price for the company. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. American Renal Associates Holdings currently has a consensus rating of “Buy” and a consensus price target of $31.80.

The company has a market capitalization of $508.15 million and a P/E ratio of 11.65. The firm’s 50 day moving average price is $0.00 and its 200-day moving average price is $0.00.

American Renal Associates Holdings (NYSE:ARA) last released its earnings results on Thursday, May 12th. The company reported $0.16 earnings per share (EPS) for the quarter. The company earned $172.10 million during the quarter, compared to analysts’ expectations of $149.30 million. On average, equities research analysts expect that American Renal Associates Holdings Inc. will post $0.88 earnings per share for the current year.

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.